![](https://www.healthcarefinancenews.com/sites/healthcarefinancenews.com/files/Blood%20test.seksanMongkhonkhamsao_0.jpg)
Cigna CEO David Cordani: 'Biosimilars represent a force of change and opportunity for continued growth'
Photo: Seksan Mongkhonkhamsao/Getty Images Cigna's profits increased to $1.9 billion during the second quarter of 2024, compared with $1.8 billion during the same quarter in 2023, according to the company's earnings report released Aug. 1. The …